SII's qHPV vaccine against cervical cancer gets DGCI's nod
SEC to discuss India's first indigenously developed vaccine again
New Delhi [India] June 15 (ANI): The first indigenously developed quadrivalent human papillomavirus (qHPV)...
COVID-19 vaccine Covovax now available for children in India
SEC seek more data from SII over Covovax for 7-12 age group
New Delhi [India], April 30 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee on...
NTAGI approves SII's Covovax for 12-17 age group: Sources
Indian jab in my arms, says UK PM; meets Adar Poonawala
New Delhi [India], April 22 (ANI): British Prime Minister Boris Johnson on Friday highlighted the collaboration...
SII CEO claims Made in India COVID vaccines better than Pfizer
New Delhi [India], April 13 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday claimed that...
India better prepared to fight any variant, says Adar Poonawalla
Covovax first Indian vaccine to be sold in Europe: SII CEO
Covishield's prices slashed for greater reach, says SII CEO
New Delhi [India], April 12 (ANI): The decision to slash the prices of the precautionary dose of the COVID-19...
Covishield price reduced from Rs 600 to Rs 225 per dose
Pune (Maharashtra) [India], April 9 (ANI): Pune-based Serum Institute of India (SII) on Saturday announced that...
Adar Poonawalla lauds Centre's work during COVID pandemic
Pune (Maharashtra) [India], April 4 (ANI): Amid the overall cases and positivity rate declining in the country...
Copyright © aninews.in | All Rights Reserved.